New handheld device lets surgery patients check vitals at home
NCT ID NCT07231653
First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times
Summary
This study tests a small, handheld device called the Wellvii VitalDetect that lets patients check their blood pressure, pulse, and temperature at home after surgery. About 69 adults will use the device twice daily for two weeks and compare results with clinic measurements. The goal is to see if the device is accurate and easy enough for patients to use on their own.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Wellvii VitalDetect (handheld vital sign monitor)
- What this could lead to
- If successful, this could show that patients can reliably monitor their own vital signs at home after surgery, potentially reducing hospital visits.
- What could go wrong
- This is a small, early-stage study with only 69 participants. The device may not be as accurate as clinic measurements, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 69 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing surgical procedures, including day surgery procedures and those procedures requiring a hospital stay
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinically stable patients requiring routine postoperative monitoring in the absence of any acute illness following surgery. * Able to use a smartphone or tablet for the monitoring system. Exclusion Criteria: * Severe cognitive impairment or conditions that may interfere with the use of home monitoring devices. * Currently participation in other clinical trials involving vital sign monitoring. * Unable to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Patient monitoring are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mackenzie Health Science Centre
Edmonton, Alberta, T6G 2B7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartwatch outperform standard tools in tracking recovery after surgery?
- Wearable sensors could spot patient decline earlier than standard checks
- Physical therapy after hernia surgery shows promise in small trial
- New study aims to predict heart trouble after stent or bypass
- New oxygen delivery method could make procedures safer and more efficient
- New wireless system aims to spot hospital patients getting worse faster